CTN CLINICAL COORDINATING CENTER TASK ORDER 9. POP 5/15/23 - 5/14/24.

CTN 临床协调中心任务单 9。POP 5/15/23 - 5/14/24。

• 批准号: 10936242
• 负责人: EVE JELSTROM
• 金额: $ 598.93万
• 依托单位: THE EMMES COMPANY, LLC
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-15 至 2024-05-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10936242
• 关键词: Clinical; clinical center

The National Drug Abuse Treatment Clinical Trials Network (CTN), funded by NIDA, was first established in 1999 to bridge the gap between research and practice to improve treatment of substance use disorders. The CTN is a means by which medical and specialty treatment providers, treatment researchers, participating patients, and NIDA can partner to cooperatively develop, validate, refine, and deliver new substance use disorder treatment options to patients. This partnership enables the conduct of behavioral, pharmacological, and integrated behavioral / pharmacological treatment interventions in rigorous, multi-site clinical trials to determine treatment effectiveness across a broad range of community-based treatment settings and diverse patient populations. This partnership also aids in the transfer of research results to physicians, clinicians, providers, and patients, supporting NIDA’s ultimate goal of enhancing the delivery of scientifically based treatments to individuals struggling with substance use disorder. Clinical investigators affiliated with the CTN propose ideas for clinical research studies and, if selected, the study is developed and conducted using the CTN platform. The Clinical Trials Network (CTN) is a collaborative framework of grant-funded nodes, a contracted Clinical Coordinating Center, a contracted Data and Statistics Center, and a contracted Logistics Support Center. Since 2005, the Emmes Company has been contracted as the Clinical Coordinating Center for the NIDA CTN.

国家药物滥用治疗临床试验网络 (CTN) 由 NIDA 资助，最初成立于 1999 年，旨在弥合研究与实践之间的差距，以改善药物滥用障碍的治疗。治疗研究人员、参与患者和 NIDA 可以合作开发、验证、完善并向患者提供新的药物使用障碍治疗方案。这种伙伴关系能够以严格、多方面的方式进行行为、药理学和综合行为/药理学治疗干预。 -地点NIDA 致力于开展临床试验，以确定广泛的社区治疗环境和不同患者群体的治疗效果，这种伙伴关系还有助于将研究成果传递给医生、主教、医疗服务提供者和患者，支持 NIDA 的最终目标：加强治疗的提供。隶属于 CTN 的临床研究人员为患有药物滥用障碍的个人提供基于科学的治疗方案，如果被选中，该研究将使用 CTN 平台（一个协作框架）进行开发和实施。赠款资助的节点，签约临床协调中心、签约数据统计中心和签约后勤支持中心 自 2005 年起，Emmes 公司成为 NIDA CTN 的签约临床协调中心。